Join today and be a part of the fastest growing B2B Network Join Now

OPDI VO nivo lumab

  • Origin: Poland
  • Supply Type: in stock
  • Processing Time: 3 Days
  • Min Order: 0

Supplier Info.

  • Employees Total 11-50
  • Annual Revenue US$2.5 Million - US$5 Million

OPD IVO® (nivo lumab) is a prescription medicine used in combination with YER VOY (ipili mumab) as a first treatment for adults with a type of advanced stage lung cancer (called non-small lung cancer) when your lung cancer has spread to other parts of your body (metastatic) and your tumors are positive for PD-L1, but do not have an abnormal EGFR or ALK gene.

OPD IVO® (nivo lumab) is a prescription medicine used in combination with YER VOY (ipili mumab) and 2 cycles of chemotherapy that contains platinum and another chemotherapy medicine, as a first treatment for adults with a type of advanced stage lung cancer (called non-small lung cancer) when your lung cancer has spread or grown, or comes back, and your tumor does not have an abnormal EGFR or ALK gene.

us for further details:

Premium Services
Need Free Quotes
Girl Right
Cross Popup
Arrow 2

I Am :

Signup today to claim your Discount. Get Started before it's too late!

Arrow 1
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok